Month: September 2025
-
Pharma patent litigation updates: Boehringer, Orion, Pfizer, Kaleo file fresh patent infringement suits in District of Delaware
The District of Delaware continues to receive a substantial volume of pharmaceutical patent infringement complaints, with an arthritis-related Pfizer suit and diabetes-related Boehringer suit among the latest.
-
Hyundai, Nissan defeat parallel automotive patent infringement complaints in Eastern District of Texas
Judge Rodney Gilstrap has ruled that Longhorn Automotive LLC’s patent infringement complaints against the automakers did not sufficiently meet the burden of proof.
-
BREAKING: ETSI creates new committee on quantum technologies
The European Telecommunications Standards Institute has approved the creation of a new Technical Committee on Quantum Technologies, ahead of a major European event on quantum ambition.
-
Munich I Regional Court’s stunning PI for 20+ countries: based on BSH, doctrine of equivalents, difficult-to-enforce formulation patent
Munich has been a patent injunction hotspot for many years, and the latest development may attract even more litigation to the venue.
-
Samsung to pay $78 million in media ad monitoring patent infringement suit, parallel suit against Roku may be revived
Anonymous Media Holdings, LLC has been granted a motion for partial summary judgment of validity in its case against Samsung.
-
AstraZeneca faces fresh mRNA patent infringement allegations in District of Delaware
Gene-editing tech company Factor Bioscience has sued AstraZeneca and its affiliate Cellectis over the infringement of three mRNA-related patents.
-
UPC Roundup (1 week): another trade fair inspection order; two UPC confidentiality decisions and one in India with reference to UPC
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our September 21, 2025 UPC Roundup.
-
Starbucks invokes anti-patent-troll state law in major defensive complaint against Key Patent Innovations and its shell company
This is one of the most notable prophylactic patent-related lawsuits because it takes aim at a non-practicing entity’s shell company from multiple angles.
-
Via LA announces semiconductor memory patent pool program: first in series of semiconductor-related licensing programs
Via Licensing Alliance has announced plans to launch a patent pool program dedicated to licensing semiconductor memory technologies, as part of a new series of programs that will span the semiconductor industry.
-
Affirmance of Brazilian preliminary injunction dissuaded BYD from 4G holdout, paved way to Avanci license-based settlement
The sequence of events suggests that the denial of BYD’s motion for reconsideration led to a settlement at this point.